TO ENROLL OR LEARN MORE
8:00 AM–8:00 PM (ET) Monday–Friday.
Spanish-speaking Case Specialists are also available.
If you have private insurance, you may be eligible for the $0 Co-pay Program.
You may be able to receive up to $12,000 in assistance per year, regardless of income
Assistance is awarded per patient. Multiple members of the same household can apply
Enrollment can be started and completed in one short phone call
Enroll today for up to one-month supply (new!)§
KOVALTRY® is delivered to your home
Any patient who has not experienced KOVALTRY® is able to participate, regardless of type of insurance or if you have insurance
Earn points that can be redeemed for KOVALTRY at no cost if you experience gaps or challenges with insurance coverage.
Enroll now and get a year’s worth of Loyalty points!
Consult with an expert in insurance
Multiple languages, including Spanish, are available
8:00 AM–8:00 PM (ET)
Spanish-speaking Case Specialists
are also available.
You can download and/or print the forms below, and your doctor, nurse, HTC, or social worker can help you complete them.Download the enrollment form for the $0 Product Co-pay, Free Trial, and Loyalty Programs, and for Benefit Verification
*Co-pay support is available for up to 12 months. Eligible patients can re-enroll for additional 12-month period.
†Patients who are enrolled in any type of government insurance are not eligible. Bayer reserves the right to rescind, revoke, or amend this offer without notice at any time.
‡Patients currently using KOVALTRY are not eligible for a Free Trial of KOVALTRY. Participation in the KOVALTRY Free Trial Program is limited to 1 time only per product. The Free Trial Program includes up to one-month supply (new!) to a maximum of 40,000 IU.
§The medication provided through this program is at no cost to the patient and is not contingent on future use of this medication. Reselling or billing any third party for free product provided by this program is prohibited by law llYou may redeem multiple points as long as you do not exceed the maximum levels for that product.
†You may redeem multiple points as long as you do not exceed the maximum levels for that product.
‡The KOVALTRY® Free Trial Program is available to newly diagnosed patients and patients who are currently using other therapy. Patients currently using KOVALTRY® are not eligible for the Free Trial Program. Participation in the KOVALTRY® Free Trial Program is limited to 1 time only. The medication provided through this program is at no cost to patients and is not an obligation to purchase or use KOVALTRY® in the future. Reselling or billing any third party for the free product is prohibited by law.
§The KOVALTRY® Free Trial Program includes up to one-month supply (new!) supply to a maximum of 5,000 IU for new patients and 40,000 IU for previously treated patients.
llPeople with private, commercial health insurance may receive KOVALTRY® co-pay or co-insurance assistance based on eligibility requirements. The program is on a first-come, first-served basis. Financial support is available for up to 12 months. Eligible patients can re-enroll for additional 12-month courses. The program is not for patients receiving prescription coverage for product under any federal-, state-, or government-funded insurance programs, or where prohibited by law. All people who meet these criteria are encouraged to apply. Bayer reserves the right to discontinue the program at any time.
KOVALTRY® is a medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A.
KOVALTRY is used to treat and control bleeding in adults and children with hemophilia A. KOVALTRY can reduce the number of bleeding episodes in adults and children with hemophilia A when used regularly (prophylaxis). Your healthcare provider may give you KOVALTRY when you have surgery.
KOVALTRY is not used to treat von Willebrand Disease.
IMPORTANT SAFETY INFORMATION
You should not use KOVALTRY if you are allergic to rodents (like mice and hamsters) or any ingredients in KOVALTRY.
Tell your healthcare provider if you have heart disease or are at risk for heart disease.
The common side effects of KOVALTRY are headache, fever, and itchy rash, in addition to inhibitors in patients who were not previously treated or minimally treated with Factor VIII products.
Your body may make antibodies, called “inhibitors” against KOVALTRY, which may stop KOVALTRY from working properly. If your bleeding is not adequately controlled, it could be due to the development of Factor VIII inhibitors. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to Factor VIII.
Allergic reactions may occur with KOVALTRY. Call your healthcare provider right away and stop treatment if you get tightness of the chest or throat, dizziness, decrease in blood pressure, and nausea.
Tell your healthcare provider about any side effect that bothers you or that does not go away.
Call your healthcare provider right away if bleeding is not controlled after using KOVALTRY.
For additional important risk and use information, please see full Prescribing Information.
You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
© 2021 Bayer. All rights reserved.
Bayer, the Bayer Cross, and KOVALTRY are registered trademarks of Bayer.
Access Services by Bayer is a trademark of Bayer.
Site Last Modified 02/2021